UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EP294/#363 Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+ platinum-resistant ovarian cancer in 2nd/3rd line of therapy

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A199-A200

2023

Volltextzugriff (PDF)

Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.556-556

2019

Volltextzugriff (PDF)

Final analysis of nelipepimut-S plus GM-CSF with trastuzumab versus trastuzumab alone to prevent recurrences in high-risk, HER2 low-expressing breast cancer: A prospective, randomized, blinded, multicenter phase IIb trial

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.1-1

2019

Volltextzugriff (PDF)

Cyclo‐oxygenase‐2 inhibitors or nonselective NSAID s plus gastroprotective agents: what to prescribe in daily clinical practice?

Alimentary pharmacology & therapeutics, 2013-07, Vol.38 (2), p.178-189

2013

Volltextzugriff (PDF)

A phase II study of sunitinib (S) plus erlotinib (E) in advanced renal carcinoma (RCC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4528-4528

2010

Volltextzugriff (PDF)

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e15165-e15165

2011

Volltextzugriff (PDF)

Comparison of Estimated Effects of Air Pollution on Human Mortality Calculated Via S-Plus and SAS

Epidemiology (Cambridge, Mass.), 2009-11, Vol.20, p.S153-S154

2009

Volltextzugriff (PDF)

Public health. Air pollution concerns not changed by S-PLUS flaw

Science (American Association for the Advancement of Science), 2003-01, Vol.299 (5607), p.665

2003

Volltextzugriff (PDF)

Analyzing Medical Data Using S-PLUS: Brian Everitt, Sophia Rabe-Hesketh. Heidelberg: Springer, 2001, pp. 485, L59.00 (HB) ISBN: 0 387 98862 9. Statistics for Biology and Health, XII. Dietz K, Gail M, Krickeberg K et al. (eds)

International journal of epidemiology, 2003-02, Vol.32 (1), p.167

May, Margaret

2003

Volltextzugriff (PDF)

Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.16023-16023

2008

Volltextzugriff (PDF)

Analyzing Medical Data Using S-PLUS

International journal of epidemiology, 2003-02, Vol.32 (1), p.167-168

May, Margaret

2003

Volltextzugriff (PDF)

Multidisciplinary data review and analysis to fulfill NIH data sharing requirements via S-Plus server

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P72-P72

2005

Volltextzugriff (PDF)

Phase II study of TS-1 (S) plus cisplatin (P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.18070-18070

2007

Volltextzugriff (PDF)

Sorafenib (S) plus gemcitabine (G) for advanced pancreatic cancer (PC): A phase II trial of the University of Chicago Phase II Consortium

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4608-4608

2007

Volltextzugriff (PDF)

P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S658-S658

2007

Volltextzugriff (PDF)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2129-2129

2004

Volltextzugriff (PDF)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2129-2129

2004

Volltextzugriff (PDF)

Statistical Computing, An Introduction to Data Analysis Using S-Plus/The Statistical Evaluation of Medical Tests for Classification and Prediction/Introductory Biostatistics

Clinical chemistry (Baltimore, Md.), 2003-11, Vol.49 (11), p.1959

Henderson, A Ralph

2003

Volltextzugriff (PDF)

Determination of the Kinetics of Na + /H + Exchange in Platelets Using the Coulter S-Plus Cell Counter

Clinical chemistry and laboratory medicine, 1994, Vol.32 (2), p.57-60

1994

Volltextzugriff (PDF)

Siemens MicroScan Synergies Plus Negative Panels

Biomedical safety & standards, 2013-11, Vol.43 (19), p.145-147

2013

Volltextzugriff (PDF)

Statistical software for microcomputers: SC-Statistical Calculator Version 1.4, S-PLUS for Windows, MINITAB for Windows, Release 10 Xtra

British journal of mathematical & statistical psychology, 1996-05, Vol.49 (1), p.203-208

1996

Volltextzugriff (PDF)

The Coulter Counter Model S Plus- the shape of things to come

Clinical and laboratory haematology, 1979-03, Vol.1 (1), p.29-40

1979

Volltextzugriff (PDF)

A comparison of differential white blood cell counts using manual technic and the coulter® S-plus IV

American journal of clinical pathology, 1985-09, Vol.84 (3), p.348-350

1985

Volltextzugriff (PDF)

Statistical software for microcomputers: S-PLUS, SYSTAT and ML3

British journal of mathematical & statistical psychology, 1991-05, Vol.44 (1), p.237-249

1991

Volltextzugriff (PDF)

Analysis of leucocyte populations with the Coulter S-Plus STKR as a screening tool for haematological abnormalities

Clinical and laboratory haematology, 1991-03, Vol.13 (1), p.51-66

1991

Volltextzugriff (PDF)

1 – 25 von 221.294

Suche als RSS-Feed

Aktive Filter

PublikationsformTexte

ThemaScience & Technology

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(201.527)
Mit Volltextzugriff
(185.881)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Social Sciences
(45.538)
Humans
(43.538)
Psychology
(29.597)
Male
(25.562)
Female
(25.517)
Biological And Medical Sciences
(22.980)
Human
(14.007)
Fundamental And Applied Biological Sciences. Psychology
(13.254)
Adult
(13.133)
Studies
(12.130)
Animals
(11.492)
Medical Sciences
(10.680)
Medicine
(10.387)
Psychology. Psychoanalysis. Psychiatry
(10.126)
Middle Aged
(9.202)
Medicine & Public Health
(9.087)
Business & Economics
(8.438)
Psychology, Clinical
(7.980)
Education
(7.716)
Patients
(6.989)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Journals@Ovid
(221.294)
Ingenta
(79.002)
EZB Electronic Journals Library
(68.247)
Wiley Online Journals
(56.696)
MEDLINE
(53.254)
SpringerNature Journals
(49.342)
Single Journals
(39.666)
Wiley Online Library Full Collection 2018
(39.015)
EZB-NALI2-00462 Springer Archive NL
(37.924)
IngentaConnect Journals
(34.501)
Access via ScienceDirect (Elsevier)
(22.806)
JSTOR
(18.867)
EBSCOhost Business Source Ultimate
(16.372)
EBSCOhost Psychology and Behavioral Sciences Collection
(16.130)
EBSCOhost APA PsycARTICLES
(15.556)
Applied Social Sciences Index & Abstracts (ASSIA)
(15.166)
SAGE Complete
(15.149)
Nexis Uni
(13.173)
Oxford journals
(13.063)
Sociological Abstracts
(10.157)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Reactions Weekly
(5.951)
Nature
(2.625)
The Lancet
(2.340)
The New England Journal Of Medicine
(2.114)
The Journal Of Clinical Investigation
(1.852)
Pharmacoeconomics & Outcomes News
(1.850)
Cancer
(1.768)
Endocrinology
(1.592)
The Journal Of Nutrition
(1.544)
Canadian Journal Of Chemistry
(1.531)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

EP294/#363 Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+ platinum-resistant ovarian cancer in 2nd/3rd line of therapy

Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence

Final analysis of nelipepimut-S plus GM-CSF with trastuzumab versus trastuzumab alone to prevent recurrences in high-risk, HER2 low-expressing breast cancer: A prospective, randomized, blinded, multicenter phase IIb trial

Cyclo‐oxygenase‐2 inhibitors or nonselective NSAID s plus gastroprotective agents: what to prescribe in daily clinical practice?

A phase II study of sunitinib (S) plus erlotinib (E) in advanced renal carcinoma (RCC)

Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC)

Comparison of Estimated Effects of Air Pollution on Human Mortality Calculated Via S-Plus and SAS

Public health. Air pollution concerns not changed by S-PLUS flaw

Analyzing Medical Data Using S-PLUS: Brian Everitt, Sophia Rabe-Hesketh. Heidelberg: Springer, 2001, pp. 485, L59.00 (HB) ISBN: 0 387 98862 9. Statistics for Biology and Health, XII. Dietz K, Gail M, Krickeberg K et al. (eds)

Sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC): Updated phase I results from a phase I/II trial (NCI 6981)

Analyzing Medical Data Using S-PLUS

Multidisciplinary data review and analysis to fulfill NIH data sharing requirements via S-Plus server

Phase II study of TS-1 (S) plus cisplatin (P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Sorafenib (S) plus gemcitabine (G) for advanced pancreatic cancer (PC): A phase II trial of the University of Chicago Phase II Consortium

P2-217: Phase II study of TS-1(S) plus cisplatin(P) with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC)

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Phase I trial of the multi-drug resistance (MDR) Protein-1 (MRP-1) modulating agent sulindac (S) plus epirubicin (E) in patients (pts) with advanced cancer

Statistical Computing, An Introduction to Data Analysis Using S-Plus/The Statistical Evaluation of Medical Tests for Classification and Prediction/Introductory Biostatistics

Determination of the Kinetics of Na + /H + Exchange in Platelets Using the Coulter S-Plus Cell Counter

Siemens MicroScan Synergies Plus Negative Panels

Statistical software for microcomputers: SC-Statistical Calculator Version 1.4, S-PLUS for Windows, MINITAB for Windows, Release 10 Xtra

The Coulter Counter Model S Plus- the shape of things to come

A comparison of differential white blood cell counts using manual technic and the coulter® S-plus IV

Statistical software for microcomputers: S-PLUS, SYSTAT and ML3

Analysis of leucocyte populations with the Coulter S-Plus STKR as a screening tool for haematological abnormalities

Aktive Filter

Suchergebnisse filtern